Optimizing protocols for monitoring in vivo replication of a novel chimeric Marek’s disease vaccine with an insertion of the long terminal repeat of reticuloendotheliosis virus in the CVI988 strain genome (CVI-LTR)

References

• Baigent, S., Nair, V. & Currie, R. (2006). Real-time quantitative PCR for Marek’s disease vaccine virus in feather samples: applications and opportunities. Journal of Developmental Biology, 126, 271–281.
   Google Scholar
• Baigent, S.J., Smith, L.P., Currie, R.J. & Nair, V.K. (2007). Correlation of Marek’s disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathology, 36, 467–474.
   PubMed Web of Science ®Google Scholar
• Biggs, P.M., Purchase, H.G., Bee, B.R. & Dalton, P.J. (1965). Preliminary report on acute Marek’s disease (fowl paralysis). Veterinary Record, 77, 1339–1340.
   PubMed Web of Science ®Google Scholar
• Bülow, V.V. & Lorenz, R.J. (1973). Plaque assay of turkey herpesvirus and attenuated Marek’s disease virus. Zentralblatt für Veterinärmedizin, 20, 161–165.
   PubMedGoogle Scholar
• Calnek, B.W., Schat, K.A., Peckham, M.C. & Fabricant, J. (1983). Field trials with a bivalent vaccine (HVT and SB-1) against Marek’s disease. Avian Diseases, 27, 844–849.
   PubMed Web of Science ®Google Scholar
• Churchill, A.E. & Biggs, P.M. (1967). Agent of Marek’s disease in tissue culture. Nature, 215, 528–530.
   PubMed Web of Science ®Google Scholar
• Churchill, A.E., Chubb, R.C. & Baxendale, W. (1969). The attenuation with loss of oncogenicity of the herpes-type virus of Marek’s disease (strain HPRS-16) on passage in cell culture. Journal of General Virology, 4, 557–564.
   PubMed Web of Science ®Google Scholar
• Churchill, A.E., Payne, L.N. & Chubb, R.C. (1969). Immunization against Marek’s disease using a live attenuated virus. Nature, 221, 744–747.
   PubMed Web of Science ®Google Scholar
• Cortes, A.L., Montiel, E.R. & Gimeno, I.M. (2009). Validation of Marek’s disease diagnosis and monitoring of Marek’s disease vaccines from samples collected in FTA cards. Avian Diseases, 53, 510–516.
   PubMed Web of Science ®Google Scholar
• Cortes, A.L., Montiel, E.R., Lemiere, S. & Gimeno, I.M. (2011). Comparison of blood and feather pulp samples for the diagnosis of Marek’s disease and for monitoring Marek’s disease vaccination by real time PCR. Avian Diseases, 55, 302–310.
   PubMed Web of Science ®Google Scholar
• Ellington, C., Cortes, A.L., Faiz, N.M., Mays, J.K., Fadly, A., Silva, R.F., & Gimeno, I.M. (2021). Characterization of Md5-BAC-REV-LTR virus as Marek’s disease vaccine in commercial meat-type chickens: protection and immunosuppression. Avian Pathology, 50, 490–499.
   PubMed Web of Science ®Google Scholar
• Faiz, N.M., Cortes, A.L., Guy, J.S., Fogle, J.E. & Gimeno, I.M. (2016). Efficacy of various Marek’s disease vaccines protocols for prevention of Marek’s disease virus-induced immunosuppression. Vaccine, 34, 4180–4187.
   PubMed Web of Science ®Google Scholar
• Gimeno, I.M., Cortes, A.L., Faiz, N.M., Barbosa, T. & Villalobos, T. (2015). Evaluation of factors influencing efficacy of vaccine strain CVI988 against Marek’s disease in meat-type chickens. Avian Diseases, 59, 400–409.
   PubMed Web of Science ®Google Scholar
• Gimeno, I.M., Cortes, A.L., Montiel, E.R., Lemiere, S. & Pandiri, A.R. (2011). Effect of diluting Marek’s disease vaccines on the outcomes of Marek’s disease virus infection when challenge with highly virulent Marek’s disease viruses. Avian Diseases, 55, 263–272.
   PubMed Web of Science ®Google Scholar
• Gimeno, I.M., Cortes, A.L. & Silva, R.F. (2008). Load of challenge Marek’s disease virus DNA in blood as a criterion for early diagnosis of Marek’s disease tumors. Avian Diseases, 52, 203–208.
   PubMed Web of Science ®Google Scholar
• Gimeno, I.M., Cortes, A.L., Witter, R.L. & Pandiri, A.R. (2012). Optimization of the protocols for double vaccination against Marek’s disease using commercially available vaccines: evaluation of protection, vaccine replication, and activation of T cells. Avian Diseases, 56, 295–305.
   PubMed Web of Science ®Google Scholar
• Gimeno, I.M., Dunn, J.R., Cortes, A.L., El-Gohary, A.E.-G. & Silva, R.F. (2014). Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek’s disease viruses. Avian Diseases, 58, 232–243.
   PubMed Web of Science ®Google Scholar
• Gimeno, I.M., Witter, R.L., Hunt, H.D., Reddy, S.M. & Reed, W.M. (2004a). Biocharacteristics shared by highly protective vaccines against Marek’s disease. Avian Pathology, 33, 59–68.
   PubMed Web of Science ®Google Scholar
• Gimeno, I.M., Witter, R.L., Hunt, H.D., Reddy, S.M. & Reed, W.M. (2004b). Biocharacteristics shared by highly protective vaccines against Marek’s disease. Avian Pathology, 33, 59–68.
   PubMed Web of Science ®Google Scholar
• ICTVdB-Management. (2006). 00.031.1.03 Mardivirus. In C. Buchen-Osmond ICTVdB- The universal virus database, version 4: Columbia University, New York, USA.
   Google Scholar
• Landman, W.J. & Verschuren, S.B. (2003). Titration of Marek’s disease cell-associated vaccine virus (CVI 988) of reconstituted vaccine and vaccine ampoules from Dutch hatcheries. Avian Diseases, 47, 1458–1465.
   PubMed Web of Science ®Google Scholar
• Lopez de Juan Abad, B., Cortes, A.L., Correa, M. & Gimeno, I.M. (2019). Evaluation of factors that influence dose variability of Marek’s disease vaccines. Avian Diseases, 63, 591–598.
   PubMed Web of Science ®Google Scholar
• Lupiani, B., Lee, L.F., Cui, X., Gimeno, I., Anderson, A., Morgan, R.W., Silva, R.F., Witter, R.L., Kung, H.-J., & Reddy, S.M. (2004). Marek’s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proceedings of the National Academy of Science USA, 101, 11815–11820.
   PubMed Web of Science ®Google Scholar
• Lupiani, B., Lee, L.F., Kreager, K.S., Witter, R.L. & Reddy, S.M. (2013). Insertion of reticuloendotheliosis virus long terminal repeat into the genome of CVI988 strain of Marek’s disease virus results in enhanced growth and protection. Avian Diseases, 57, 427–431.
   PubMed Web of Science ®Google Scholar
• Marek, J. (1907). Multiple nervenentzündung (polyneuritis) bei hühnern. Deutsche Tierarztlich Wochenschrift, 15, 417–421.
   Google Scholar
• Morgan, R.W., Gelb, Jr., J., Schreurs, C.S. & Sondermeijer, P.J.A. (1992). A live recombinant HVT vaccine expressing the Newcastle Disease virus fusion protein protects chickens from both Newcastle and Marek’s diseases. In 4th International Symposium on Marek’s Disease, 19th World’s Poultry Congress, Vol. 1 (pp. 323–327). Amsterdam: World’s Poultry Science Assn.
   Google Scholar
• Nazerian, K., Yanagida, N., Lee, L.F. & Ogawa, R. (1992). Expression of Marek’s disease (MD) virus genes in recombinant fowlpox virus and protection of chickens against MD. In 4th International Symposium on Marek’s Disease, 19th World’s Poultry Congress, Vol. 1 (pp. 136–139). Amsterdam: World’s Poultry Science Assn.
   Google Scholar
• Pritchard, J., Mebatsion, T. & Bublot, M. (2022). Modified Marek’s disease virus, and vaccines made therefrom. In U.P. Office (Ed.) (p. 16). Boehringer Ingelheim Animal Health USA Inc.
   Google Scholar
• Reddy, S.M., Izumiya, Y. & Lupiani, B. (2017). Marek’s disease vaccines: current status, and strategies for improvement and development of vector vaccines. Veterinary Microbiology, 206, 113–120.
   PubMed Web of Science ®Google Scholar
• Rispens, B.H., Van Vloten, J., Mastenbroek, N., Maas, H.J.L. & Hendrick, J.L. (1972a). Control of Marek’s disease in The Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek’s disease virus. Avian Diseases, 16, 126–138.
   PubMed Web of Science ®Google Scholar
• Rispens, B.H., Van Vloten, J., Mastenbroek, N., Maas, H.J.L. & Schat, K.A. (1972b). Control of Marek’s disease in The Netherlands. I. Isolation of an avirulent Marek’s disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Diseases, 16, 108–125.
   PubMed Web of Science ®Google Scholar
• Schat, K.A. (2016). History of the first-generation Marek’s disease vaccines: the science and little-known facts. Avian Diseases, 60, 715–724.
   PubMed Web of Science ®Google Scholar
• Schat, K.A. & Calnek, B.W. (1978). Characterization of an apparently nononcogenic Marek’s disease virus. Journal of the National Cancer Institute, 60, 1075–1082.
   PubMed Web of Science ®Google Scholar
• Sun, F., Ferro, P.J., Lupiani, B., Kahl, J., Morrow, M.E., Flanagan, J.P., Estevez, C., & Clavijo, A. (2011). A duplex real-time polymerase chain reaction assay for the simultaneous detection of long terminal repeat regions and envelope protein gene sequences of reticuloendotheliosis virus in avian blood samples. Journal of Veterinary Diagnostic Investigation, 23, 937–941.
   PubMed Web of Science ®Google Scholar
• Witter, R.L. & Kreager, K.S. (2004). Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek’s disease. Avian Diseases, 48, 768–782.
   PubMed Web of Science ®Google Scholar
• Witter, R.L., Li, D., Jones, D., Lee, L.F. & Kung, H.J. (1997). Retroviral insertional mutagenesis of a herpesvirus: a Marek’s disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication. Avian Diseases, 41, 407–421.
   PubMed Web of Science ®Google Scholar
• Witter, R.L., Nazerian, K., Purchase, H.G. & Burgoyne, G.H. (1970). Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek’s disease virus. American Journal of Veterinary Research, 31, 525–538.
   PubMed Web of Science ®Google Scholar
• Witter, R.L. & Sharma, J.M. (1983). Polyvalent Marek’s disease vaccines – a strategy to protect chickens against challenge with very virulent Marek’s disease virus strains. In Proc.18th Natl.Mtg.Poultry Health & Condemnations (pp. 138–148).
   Google Scholar